For example, ovarian cancer cells overexpressing GGT1 are resistant to chemotherapies, such as cisplatin51 and 5-fluorouracil52, indicating that the development of a potent inhibitor of GGT1 might represent a new therapeutic strategy. This evidence concerns the gene GGT1 and ovarian cancer.